Study Finds No Statistical Link Between Use of Semaglutide and Other GLP-1 Drugs and Risk of Degenerative Eye Disease in Adults with Type 2 Diabetes
July 18: An estimated 27 percentage of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists – a type…
